tiprankstipranks
Aspira Women’s Health CFO Resignation and Leadership Update
Company Announcements

Aspira Women’s Health CFO Resignation and Leadership Update

Story Highlights

Stay Ahead of the Market:

Aspira Women’s Health ( (AWH) ) has issued an announcement.

Aspira Women’s Health Inc. announced the resignation of its Interim Chief Financial Officer, John Kallassy, effective January 10, 2025, due to personal reasons. Dr. Sandra Milligan, the CEO, will take over as the principal accounting officer, and her full salary has been reinstated retroactively to December 16, 2024.

More about Aspira Women’s Health

YTD Price Performance: 4.60%

Average Trading Volume: 102,493

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $12.5M

See more data about AWH stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskAspira Women’s Health CEO Transition and Leadership Change
TheFlyAkari Therapeutics appoints Torsten Hombeck as CFO
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App